XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statement of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income attributable to common shareholders $ 6,796,695 $ (71,259)
Amortization (accretion) of investments 2,218,898 (3,195,015)
Realized investment gains, net (11,238,250) (2,221,888)
Unrealized trading gains included in income 281,685 1,412,630
Amortization of deferred policy acquisition costs 46,536 51,519
Amortization of cost of insurance acquired 859,126 923,261
Depreciation 959,836 1,048,126
Net income attributable to noncontrolling interest 626,590 (40,469)
Charges for mortality and administration of universal life and annuity products (5,281,297) (5,547,734)
Interest credited to account balances 3,725,149 3,915,979
Change in accrued investment income (loss) (974,807) 371,310
Change in reinsurance receivables 1,507,932 1,748,548
Change in policy liabilities and accruals (2,422,859) (3,856,527)
Change in income taxes receivable (payable) 2,259,832 (3,260,867)
Change in other assets and liabilities, net (935,954) 2,358,592
Net cash provided by (used in) operating activities (1,570,888) (6,363,794)
Cash flows from investing activities:    
Fixed maturities available for sale 84,519,249 130,999,311
Equity securities available for sale 1,287,475 3,231,410
Trading securities 15,344,038 14,209,807
Mortgage loans 4,134,379 2,984,255
Discounted mortgage loans 7,195,550 10,288,755
Real estate 9,499,500 9,921,610
Policy loans 2,782,021 3,478,803
Total proceeds from investments sold and matured 124,762,212 175,113,951
Cost of investments acquired:    
Fixed maturities available for sale (122,811,049) (125,182,803)
Equity securities available for sale (11,938,273) (781,307)
Trading securities (12,876,567) (4,641,579)
Mortgage loans (17,513,757) (846)
Discounted mortgage loans (6,146,295) (10,378,446)
Real estate (9,299,718) (12,431,325)
Policy loans (4,194,686) (2,862,585)
Total cost of investments acquired (184,780,345) (156,278,891)
Sale/Purchase of property and equipment 17,440 (204,475)
Net cash used in investing activities (60,000,693) 18,630,585
Cash flows from financing activities:    
Policyholder contract deposits 4,382,637 4,743,069
Policyholder contract withdrawals (4,664,817) (4,690,873)
Proceeds from notes payable/line of credit 1,411,000 5,613,000
Payments of principal on notes payable/line of credit (2,827,206) (3,958,284)
Purchase of treasury stock (781,124) (443,282)
Distributions to minority interests of consolidated subsidiaries (160,000) (388,275)
Cash received in reinsurance recapture 2,480,706 0
Net cash provided by (used in) financing activities (158,804) 875,355
Net increase (decrease) in cash and cash equivalents (61,730,385) 13,142,146
Cash and cash equivalents at beginning of period 82,925,675 18,483,452
Cash and cash equivalents at end of period $ 21,195,290 $ 31,625,598